Loading...
HATAY PHARMACEUTICAL JOINT STOCK CO — Insulin Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #16 buyer for Insulin · $633.2K import value · 20 shipments · VIETNAM · DGFT Verified
HATAY PHARMACEUTICAL JOINT STOCK CO is the #16 importer of Insulin from India with $633.2K in import value and 20 verified shipments. HATAY PHARMACEUTICAL JOINT STOCK CO holds a 1.3% market share in Insulin imports based in VIETNAM. The company sources from 1 verified supplier across 13 formulations shipped to 2 countries. Overall, HATAY PHARMACEUTICAL JOINT STOCK CO imports 2 pharmaceutical products worth $1.2M across 2 therapeutic categories.
Verified from 20 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| WOCKHARDT LIMITED | $633.2K | 20 | 100.0% |
HATAY PHARMACEUTICAL JOINT STOCK CO sources Insulin from 1 verified Indian supplier based on 20 customs records. The primary supplier is WOCKHARDT LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #16 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | ELI LILLY PAKISTAN (PRIVATE) LTD | PAKISTAN | $1.6M | 34 | $45.8K |
| 11 | ELI LILLY PAKISTAN (PVT ) LTD | PAKISTAN | $1.3M | 25 | $50.0K |
| 16 | HATAY PHARMACEUTICAL JOINT STOCK CO ★ | VIETNAM | $1.0M | 20 | $50.0K |
| 10 | PHARMARIS PERU S.A.C. | PERU | $900.0K | 18 | $50.0K |
| 13 | NEW GPC INC | GUYANA | $900.0K | 18 | $50.0K |
HATAY PHARMACEUTICAL JOINT STOCK CO ranks #16 among 384 Insulin importers from India. Average shipment value of $50.0K compared to the market average of $69.0K. The closest competitors by value are ELI LILLY PAKISTAN (PRIVATE) LTD and ELI LILLY PAKISTAN (PVT ) LTD.
Destination countries from 20 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| VIETNAM | $485.6K | 14 | 76.7% |
| VIETNAM, DEMOCRATIC REP. OF | $147.6K | 6 | 23.3% |
HATAY PHARMACEUTICAL JOINT STOCK CO imports Insulin to 2 countries. The primary destination is VIETNAM receiving 76.7% of shipments worth $485.6K.
| Formulation | Value | Shipments |
|---|---|---|
| GLARITUS DISPOPEN - 2 (INSULIN GLARGINEINJECTION 100IU/ML, 3ML) | $119.7K | 4 |
| WOSULIN 30 70 40IU ML 10ML VIAL BIPHASIC ISOPHANE INSULIN INJECTION BP | $100.0K | 2 |
| GLARITUS CARTRIDGE 100IU ML 3ML 1 S INSULIN GLARGINE INJECTION BP 100IU ML | $100.0K | 2 |
| WOSULIN 30 70 100IU ML 3ML CARTRIDGE 1 S BIPHASIC ISOPHANE INSULIN INJECTIONBP | $50.0K | 1 |
| GLARITUS DISPOPEN 100IU ML 3ML 1 S INSULIN GLARGINE INJECTION 100IU ML | $50.0K | 1 |
| WOSULIN 30/70 DISPOPEN 100IU/ML, 3ML (BIPHASIC ISOPHANE INSULIN INJECTION 100IU/ML) | $50.0K | 1 |
| WOSULIN 30/70 CARTRIDGE 100IU/ML, 3ML (BIPHASIC ISOPHANE INSULIN INJECTION 100IU/ML) [1'S] | $50.0K | 1 |
| WOSULIN R 40IU ML 10ML VIALS INSULIN HUMAN INJECTION USP HUMAN RECOMBINANT R DNA |
India exported $26.5M worth of Insulin through 2,532 shipments from 188 suppliers to 111 countries, serving 384 buyers globally. HATAY PHARMACEUTICAL JOINT STOCK CO imports $633.2K of this total, accounting for 1.3% of India's Insulin exports with 20 shipments from VIETNAM. This is verified from 20 customs shipment records covering 13 distinct formulations.
HATAY PHARMACEUTICAL JOINT STOCK CO's average Insulin order value is $31.7K per consignment, based on 20 shipments totaling $633.2K. HATAY PHARMACEUTICAL JOINT STOCK CO is based in VIETNAM and ranks #16 among all Insulin importers from India by value. The company sources from 1 verified supplier in India.
HATAY PHARMACEUTICAL JOINT STOCK CO sources Insulin from 1 verified Indian supplier: WOCKHARDT LIMITED ($633.2K, 100.0%). This is based on 20 customs records.
HATAY PHARMACEUTICAL JOINT STOCK CO ranks #16 among 384 Insulin importers from India with a 1.3% market share. The top 3 importers are BJC HEALTHCARE COMPANY LIMITED ($5.7M), BERLIN PHARMACEUTICALS INDUSTRY CO. ($5.2M), BERLIN PHARMACEUTICALS INDUSTRY CO ($4.1M). HATAY PHARMACEUTICAL JOINT STOCK CO processed 20 shipments from VIETNAM.
HATAY PHARMACEUTICAL JOINT STOCK CO imports 2 products worth $1.2M. Beyond Insulin, top products include Taila. View the complete HATAY PHARMACEUTICAL JOINT STOCK CO profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Insulin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for HATAY PHARMACEUTICAL JOINT STOCK CO's Insulin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
HATAY PHARMACEUTICAL JOINT STOCK CO
Full Company Profile →
2 products · $1.2M total trade · 2 categories
| $43.4K |
| 1 |
| WOSULIN N 40IU ML 10ML VIALS ISOPHANEINSULIN HUMAN SUSPENSION USP RECOMBINANTDNA ORIGIN | $42.2K | 1 |
| WOSULIN R VIAL 40IU/ML 10ML (INSULIN INJ | $28.0K | 2 |
HATAY PHARMACEUTICAL JOINT STOCK CO imports 13 distinct Insulin formulations from India. The top formulation is GLARITUS DISPOPEN - 2 (INSULIN GLARGINEINJECTION 100IU/ML, 3 with 4 shipments worth $119.7K.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 111+ countries, 384+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for HATAY PHARMACEUTICAL JOINT STOCK CO.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Insulin. For current order-level data, contact TransData Nexus.